Michael Aldridge, SVP of Corporate & Strategic Development, will present on how novel engineered enzymes can enable enhanced NGS diagnostics at the Clinical Diagnostics Showcase (Track 5 program) on Jan 22, at 2 pm.
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
For more details, please click here: http://www.pmwcintl.com/2018sv/